INE203A01020
INE203A01020
ASTRAZENECA PHARMA INDIA LTD.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 22.725.800.000 | 17.132.900.000 | 32.6% |
| Cost of Revenue | 14.886.900.000 | 10.005.800.000 | 48.8% |
| Gross Profit | 7.838.900.000 | 7.127.100.000 | 10.0% |
| 5.492.500.000 | 4.979.000.000 | 10.3% | |
| Operating Income | 2.346.400.000 | 2.148.100.000 | 9.2% |
| Pretax Income | 2.522.000.000 | 1.563.600.000 | 61.3% |
| Net Income Common Stockholders | 1.875.200.000 | 1.157.400.000 | 62.0% |
| -- | -- | -- | |
| -- | -- | -- |